Strata Critical Medical, Inc.
NASDAQ Global MarketTotal Valuation
Strata Critical Medical, Inc. carries a market capitalization of 460.32M, placing it among publicly traded companies globally. Its enterprise value stands at 447.72M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 460.32M |
| Enterprise Value | 447.72M |
Share Statistics
Strata Critical Medical, Inc. currently has 88.47M shares outstanding.
| Shares Outstanding | 88.47M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Strata Critical Medical, Inc. trades at a trailing price-to-earnings ratio of 11.16. The price-to-sales ratio is 1.75, and the price-to-book ratio stands at 1.67.
| PE Ratio | 11.16 |
| PS Ratio | 1.75 |
| PB Ratio | 1.67 |
| P/TBV Ratio | 4.15 |
| P/FCF Ratio | -19.28 |
| P/OCF Ratio | -12.46 |
Enterprise Valuation
| EV / Sales | 1.75 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Strata Critical Medical, Inc. maintains a current ratio of 2.64, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.64 |
| Quick Ratio | 1.45 |
| Debt / Equity | 1.52 |
| Debt / EBITDA | -1.03 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | 16.01 |
| Return on Assets (ROA) | 13.62 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Strata Critical Medical, Inc.'s stock has gained approximately 27.27273% over the past 52 weeks. The 50-day moving average sits at 5.49, while the 200-day moving average is 5.09.
| Beta (5Y) | N/A |
| 52-Week Price Change | 27.27273% |
| 50-Day Moving Average | 5.49 |
| 200-Day Moving Average | 5.09 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Strata Critical Medical, Inc. generated 255.98M in revenue and converted that into 40.22M in net income, yielding earnings per share of -0.27. EBITDA reached -4.12M, while operating income came in at -20.41M.
| Revenue | 255.98M |
| Gross Profit | 52.62M |
| Operating Income | -20.41M |
| Pretax Income | -23.16M |
| Net Income | 40.22M |
| EBITDA | -4.12M |
| EBIT | -20.41M |
| Earnings Per Share (EPS) | -0.27 |
Balance Sheet
Strata Critical Medical, Inc. holds 22.75M in cash and equivalents against 4.26M in total debt, resulting in a net debt position of -16.32M. Total book value stands at 279.32M, with working capital of 75.23M providing operational flexibility.
| Cash & Cash Equivalents | 22.75M |
| Total Debt | 4.26M |
| Net Debt | -16.32M |
| Equity (Book Value) | 279.32M |
| Book Value Per Share | 3.16 |
| Working Capital | 75.23M |
Cash Flow
Strata Critical Medical, Inc. produced -36.03M in operating cash flow over the past twelve months. After subtracting -12.41M in capital expenditures, free cash flow totaled -48.45M - equivalent to -0.57 per share.
| Operating Cash Flow | -36.03M |
| Capital Expenditures | -12.41M |
| Free Cash Flow | -48.45M |
| FCF Per Share | -0.57 |
Margins
Strata Critical Medical, Inc. operates with a gross margin of 20.56, reflecting its pricing power and cost economics. The operating margin of -7.97 and net profit margin of 15.71 provide insight into operational efficiency.
| Gross Margin | 20.56 |
| Operating Margin | -7.97 |
| Pretax Margin | -9.05 |
| Profit Margin | 15.71 |
| EBITDA Margin | -1.61 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 1.84 |
| FCF Yield | -5.19 |
Scores
Strata Critical Medical, Inc. posts an Altman Z-Score of 5.62, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.62 |